Secretion and Dipeptidyl Peptidase-4-Mediated Metabolism of Incretin Hormones after a Mixed Meal or Glucose Ingestion in Obese Compared to Lean, Nondiabetic Men

被引:115
作者
Carr, Richard D. [2 ]
Larsen, Marianne O. [2 ]
Jelic, Katarina [2 ]
Lindgren, Ola [1 ]
Vikman, Jenny [1 ]
Holst, Jens J. [3 ]
Deacon, Carolyn F. [3 ]
Ahren, Bo [1 ]
机构
[1] Lund Univ, Div Med, Dept Clin Sci, SE-222184 Lund, Sweden
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
[3] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark
基金
瑞典研究理事会;
关键词
GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; INSULIN-SECRETION; GLP-1; SECRETION; CELL-FUNCTION; IV ACTIVITY; HEALTHY; WEIGHT; INACTIVATION; PROTEIN;
D O I
10.1210/jc.2009-2054
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are cleaved by dipeptidyl peptidase-4 (DPP-4); plasma activity of DPP-4 may be increased in obesity. The impact of this increase on incretin hormone secretion and metabolism is not known. Objective: The aim of the study was to assess incretin hormone secretion and degradation in lean and obese nondiabetic subjects. Design, Settings, and Participants: We studied the ingestion of a mixed meal (560 kcal) or oral glucose (2 g/kg) in healthy lean (n = 12; body mass index, 20-25 kg/m(2)) or obese (n = 13; body mass index, 30-35 kg/m(2)) males at a University Clinical Research Unit. Main Outcome Measures: We measured the area under the curve of plasma intact (i) and total (t) GIP and GLP-1 after meal ingestion and oral glucose. Results: Plasma DPP-4 activity was higher in the obese subjects (38.5 +/- 3.0 vs. 26.7 +/- 1.6 mmol/min . mu l; P = 0.002). Although GIP secretion (AUC(tGIP)) was not reduced in obese subjects after meal ingestion or oral glucose, AUC(iGIP) was lower in obese subjects (8.5 +/- 0.6 vs. 12.7 +/- 0.9 nmol/liter X 300 min; P < 0.001) after meal ingestion. GLP-1 secretion (AUC(tGLP-1)) was reduced in obese subjects after both meal ingestion (7.3 +/- 0.9 vs. 10.0 +/- 0.6 nmol/liter X 300 min; P = 0.022) and oral glucose (6.6 +/- 0.8 vs. 9.6 +/- 1.1 nmol/liter X 180 min; P = 0.035). iGLP-1 was reduced in parallel to tGLP-1. Conclusions: 1) Release and degradation of the two incretin hormones show dissociated changes in obesity: GLP-1 but not GIP secretion is lower after meal ingestion and oral glucose, whereas GIP but not GLP-1 metabolism is increased after meal ingestion. 2) Increased plasma DPP-4 activity in obesity is not associated with a generalized augmented incretin hormone metabolism. (J Clin Endocrinol Metab 95: 872-878, 2010)
引用
收藏
页码:872 / 878
页数:7
相关论文
共 28 条
  • [1] Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies
    Ahrén, B
    Pacini, G
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2004, 150 (02) : 97 - 104
  • [2] Incretin and islet hormonal responses to fat and protein ingestion in healthy men
    Carr, Richard D.
    Larsen, Marianne O.
    Winzell, Maria Sorhede
    Jelic, Katarina
    Lindgren, Ola
    Deacon, Carolyn F.
    Ahren, Bo
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2008, 295 (04): : E779 - E784
  • [3] Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide
    Deacon, CF
    Nauck, MA
    Meier, J
    Hücking, K
    Holst, JJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) : 3575 - 3581
  • [4] Inhibitors of dipeptidyl peptidase IV:: a novel approach for the prevention and treatment of Type 2 diabetes?
    Deacon, CF
    Ahrén, B
    Holst, JJ
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (09) : 1091 - 1102
  • [5] BOTH SUBCUTANEOUSLY AND INTRAVENOUSLY ADMINISTERED GLUCAGON-LIKE PEPTIDE-I ARE RAPIDLY DEGRADED FROM THE NH2-TERMINUS IN TYPE-II DIABETIC-PATIENTS AND IN HEALTHY-SUBJECTS
    DEACON, CF
    NAUCK, MA
    TOFTNIELSEN, M
    PRIDAL, L
    WILLMS, B
    HOLST, JJ
    [J]. DIABETES, 1995, 44 (09) : 1126 - 1131
  • [6] Alpha cell function in health and disease:: influence of glucagon-like peptide-1
    Dunning, BE
    Foley, JE
    Ahrén, B
    [J]. DIABETOLOGIA, 2005, 48 (09) : 1700 - 1713
  • [7] COMPARISON OF THE RELATIONSHIP BETWEEN STRUCTURE AND CNS EFFECTS FOR LORAZEPAM, CLONAZEPAM AND ALPRAZOLAM
    ELLINWOOD, EH
    NIKAIDO, AM
    GUPTA, SK
    HEATHERLY, DG
    HEGE, S
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1993, 7 (01) : 24 - 32
  • [8] Glucose-induced incretin hormone release and inactivation are differently modulated by oral fat and protein in mice
    Gunnarsson, P. Thomas
    Winzell, Maria Sorhede
    Deacon, Carolyn F.
    Larsen, Marianne O.
    Jelic, Katarina
    Carr, Richard D.
    Ahren, Bo
    [J]. ENDOCRINOLOGY, 2006, 147 (07) : 3173 - 3180
  • [9] Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine
    Hansen, L
    Deacon, CF
    Orskov, C
    Holst, JJ
    [J]. ENDOCRINOLOGY, 1999, 140 (11) : 5356 - 5363
  • [10] The incretin system and its role in type 2 diabetes mellitus
    Holst, Jens Juul
    Vilsboll, Tina
    Deacon, Carolyn F.
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 127 - 136